RxStrategies, Inc.

RxStrategies, Inc. provides pharmacy technology solutions that enhance compliance and efficiency in the 340B Drug Pricing Program. The company focuses on optimizing pharmacy operations for healthcare providers, improving financial recovery and patient care outcomes. Founded in 2003 and headquartered in Boca Raton, US, RxStrategies, Inc.

specializes in pharmacy management solutions. The company has completed a total of 3 deals and recently raised USD 3. 460 mn in funding from Lovett Miller & Co. The current CEO is Fenton Markevich.

RxStrategies, Inc. offers advanced pharmacy solutions, including 340B technology solutions, split billing, and comprehensive pharmacy administration services. These offerings are designed to enhance compliance and streamline operations for health systems, community pharmacies, and specialty pharmacies across the United States. The company generates revenue through a service model that encompasses subscriptions and partnerships with healthcare organizations.

Clients engage RxStrategies for ongoing support, benefitting from its suite of solutions which may involve monthly or annual subscription fees, directly facilitating compliance and operational efficiency. RxStrategies is focused on expanding its offerings and markets. The company plans to introduce new products aimed at enhancing pharmacy operations and is targeting expansion into new geographic regions. Recent funding of USD 3.

460 mn will be utilized to bolster these initiatives, although specific product launch dates and targeted regions for expansion have not been disclosed.